Precision oncology webinar series: Explore advancements in genomic tumor characterization and clinical application

April 10, 2024 | COMPANY | EVENTS

Reviewed May 01, 2024

Oncological care increasingly relies on molecular tumor characterization techniques to enhance patient outcomes. However, the clinical utility of some of these methods remains uncertain, potentially affecting their integration into healthcare systems.

With all these new advancements, it can be challenging to stay up to date on the clinical applications and future prospects of these precision oncology techniques.

In case you missed it - watch on demand our latest free-to-attend webinar series, in collaboration with FrontLine Genomics, where you will:

Gain insights into the latest genomic techniques that are being used for the molecular characterization of tumors
Understand how liquid biopsies can be used in early cancer detection, patient stratification and clinical decision making
Learn, with real-world examples, how precision medicine techniques are being used clinically, both within the UK and internationally
See Katie Shepherd, Clinical Specialist at Nonacus, provide an overview of the GALEAS™ portfolio designed to support clinical oncology diagnostic and prognostic decisions. She will introduce GALEAS Tumor as a comprehensive genomic profiling tool for stratifying prevalent and rare cancers, alongside Cell3™ Target: custom NGS panel design as an aid to understand cancer evolution and patient management

Webinar information - what's on

Webinar 1: Genomics in cancer diagnostics

Held on Tuesday 16th April at 3pm BST/ 4pm CST/ 10am EDT

In this webinar, we will explore the role of genomics in cancer detection, diagnosis and tumor characterization, and its impact on oncological care.

Our speakers will discuss germline and somatic gene testing, the potential of liquid biopsies in early cancer detection, and the transformative potential of these methods in personalised cancer treatments.

Talk 1: Challenges and Opportunities for Implementing Liquid Biopsies into Routine Clinical Diagnostics – Elif Dagdan, Director, Center for Medical Genetics Bochum Germany
Talk 2: Personalized Therapy Unleashed: The Critical Role of HRD Testing – Tina Moser, Postdoctoral Researcher, Medical University Graz

Webinar 2: Molecular characterization in cancer care

Held on Tuesday 23rd April at 3pm BST/ 4pm CST/ 10am EDT

Precision oncology methods can now be used at every point of the typical patient pathway, from diagnosis to disease progression. Molecular tools are now being used that enable clinicians to monitor progression, predict relapse and metastasis, and change the course of clinical care in line with these findings.

In this webinar, we will discover how molecular cancer testing is shaping our understanding of cancer evolution, how this aids clinical decision making, and the developments we can expect in the coming years.

Talk 1: Molecular characterization of ovarian cancers & patient stratification for precision oncology – Robb Hollis, Scientist at CRUK Scotland Centre, University of Edinburgh
Talk 2: GALEAS: Precision diagnostics guiding clinical decisions- from solid tumor to liquid biopsy – Katie Shepherd, Clinical Specialist, Nonacus
Talk 3: Genomic technologies that are shaping clinical cancer care in the NHS – Gareth Gerrard, Clinical Scientist and Scientific Lead for Cancer Genomics (South East Genomic Laboratory Hub), Guy's and St Thomas' NHS Foundation Trust
Talk 4: Patient stratification & precision medicine supported by liquid biopsies – Simon Heeke, Liquid Biopsy Translational Working Group Leader, Department of Thoracic Head/ Neck Medical Oncology, MD Anderson Cancer Center

Webinar 3: Precision oncology now and in the future

Held on Tuesday 30th April at 3pm BST/ 4pm CST/ 10am EDT

Cancer has historically been the prime example of a disease that benefits from precision medicine approaches, and now we’re seeing progress in integrating these new technologies into the cancer treatment pathway.

This webinar will focus on how technologies are translating from research to the clinic, and what challenges we must overcome before these techniques become routine. It will also showcase how the management of cancer is evolving for certain types of malignancies, and what you can expect to see becoming standard practice in healthcare going forward.

Talk 1: Optimizing urinary proteomes as a liquid biopsy for prostate cancer – Thomas Kislinger, Professor, University of Toronto
Talk 2: Dynamic precision medicine: A new approach to therapy resistance – Robert Beckman, Professor of Oncology and of Biostatistics, Bioinformatics, and Biomathematics, Georgetown University Medical Center
Talk 3: Circulating tumor cells as a non-invasive glioblastoma approach to study recurrence events and develop a challenging diagnostic tool – Francesca Lessi, Researcher, Fondazione Pisana per la Scienza